North America Nuclear Imaging Systems Market Outlook (2021-2031)

The North America nuclear imaging systems market size is expected to reach US$ 2,157.58 million by 2031 from US$ 2,760.62 million in 2024. The market is estimated to record a CAGR of 3.7% from 2025 to 2031.

Executive Summary and North America Nuclear Imaging Systems Market Analysis:

The nuclear imaging market in North America is sophisticated and continues to be influenced by established healthcare systems, ongoing technology development and substantial investments in precise medicine. Hospitals and diagnostic centers continue to rely on PET/CT and SPECT systems to diagnose and treat cancer, as well as cardiovascular and neurological disorders. Private health care organizations and academic institutions are working innovatively to expand theranostics avenues. The United States remains the leader in the adoption of medical imaging due to its utilization of nuclear imaging, high volume of clinical research, and reimbursement structure. Canada is important because of the existence of universal healthcare programs and an on-going modernization, but at a smaller scale than the US. High costs and varying regulations continue to be barriers. Nevertheless, North America continues to be a world leader in nuclear imaging, due to its leadership and trend-setting nature in technology integration, radiopharmaceutical development, and clinical practice. North America remains the most commercially significant and innovative market nuclear imaging.

North America Nuclear Imaging Systems Market Segmentation Analysis:

Key segments that contributed to the derivation of the nuclear imaging systems market analysis are product type, application, and end user.

• By product type, the nuclear imaging systems market is segmented into SPECT systems, PET systems and hybrid systems. The PET systems segment dominated the market in 2024.
• By application, the nuclear imaging systems market is segmented into oncology, cardiology, neurology, endocrinology and others. The oncology segment dominated the market in 2024.
• By end user, the market is segmented into hospitals, specialty clinics, diagnostics imaging centers, academic & research Institutes and others. The hospitals segment held the largest share of the market in 2024.

North America Nuclear Imaging Systems Market Outlook

North America’s nuclear imaging market has widespread access to advanced diagnostic systems, supported by a network of manufacturers, research institutions, and healthcare providers. PET/CT and SPECT systems provide oncologists, cardiologists, and neurologists better imaging capability and frequent technological advancement also enhances the workflow. A robust radiopharmaceutical supply chain supports the consistent utilization of imaging systems. Nevertheless, operating costs and regulatory compliance are major restraining factors, but the region benefits from a large patient base and mature reimbursement environment. With increasing instances of cancer in the region, the need for precision oncology will continue to rise, increasing the usage of PET, CT, and SPECT imaging evaluation and planning of cancer treatment and management to improve overall outcomes. Evolving research funding, supported by government backing, and industry and academic collaboration, along with ever-increasing patient awareness continue to maintain consistent demand for nuclear imaging in hospitals and specialized centers.

North America Nuclear Imaging Systems Market Country Insights

Based on country, the North America nuclear imaging systems Market is further segmented into the United States, Canada and Mexico. The United States held the largest share in 2024.

The United States leads the North American nuclear imaging market, driven by its large healthcare infrastructure, advanced research programs, and widespread system adoption. It has the largest installed base of PET/CT and SPECT systems, complemented by a strong radiopharmaceutical supply and distribution network. Demand in the nuclear imaging market comes primarily from oncology, where nuclear imaging are critical in early detection, staging, diagnosis, and treatment plans. Cardiology and neurology applications also contribute, particularly in hospitals and diagnostic chains with broad access. The U.S. is active in theranostics research, with academic centers and private players developing new radiopharmaceuticals and imaging applications. Reimbursement frameworks are complex but provide solid support for providers, helping sustain adoption. Beyond clinical use, the country acts as a global innovation hub, setting standards in product development and technology integration. With high investment, strong research capacity, and significant patient demand, the U.S. continues to lead the region.

North America Nuclear Imaging Systems Market Company Profiles

GE HealthCare, Siemens Healthineers AG, Canon Inc., Koninklijke Philips N.V., SHIMADZU CORPORATION, United Imaging Healthcare Co., Ltd., Neusoft Medical Systems Co., Ltd., Mediso Ltd., Positron Corporation, and MiE GmbH are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.

North America Nuclear Imaging Systems Market Research Methodology:

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

Primary Research

Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:

• Refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Key Sources Referred:

• The World Bank
• World Health Organization (WHO)
• Center for Disease Control and Prevention (CDC)
• Society of Nuclear Medicine and Molecular Imaging (SNMMI)
• European Association of Nuclear Medicine (EANM)
• American College of Nuclear Medicine (ACNM)
• American Society of Nuclear Cardiology (ASNC)
• Global Cancer Observatory
• Company website
• Company annual reports
• Company investor presentations

North America Nuclear Imaging Systems Market Strategic Insights

North America Nuclear Imaging SystemsMarket Report Highlights

North America Nuclear Imaging Systems Market Country and Regional Insights